Assignee profile:

PERSEUS PROTEOMICS INC.

City:

Tokyo

Country:

Japan

Published Applications:

39

Last publication date:

2025-08-21

Patent Grants:

27

Last grant date:

2024-04-09

Top Inventors for applications by PERSEUS PROTEOMICS INC.

These are the the leading inventors for applications assigned to PERSEUS PROTEOMICS INC.:

Recent patent applications by PERSEUS PROTEOMICS INC.

PERSEUS PROTEOMICS INC. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-08-21
US20250263497A1
Chemistry; metallurgy

THERAPEUTIC AGENT FOR NK-CELL TUMOR

#2 | 2024-10-24
US20240352142A1
Chemistry; metallurgy

ROS (REACTIVE OXYGEN SPECIES) PRODUCTION ENHANCING AGENT

#3 | 2024-08-29
US20240288453A1
Physics

METHOD FOR DETERMINING MEDICINAL EFFECT OR SENSITIVITY OF ANTI-TRANSFERRIN RECEPTOR ANTIBODY

#4 | 2023-08-10
US20230250180A1
Chemistry; metallurgy

THERAPEUTIC DRUG FOR CARCINOMATOUS PERITONITIS

#5 | 2023-07-13
US20230220098A1
Chemistry; metallurgy

THERAPEUTIC DRUG FOR POLYCYTHEMIA

#6 | 2022-10-20
US20220332838A1
Chemistry; metallurgy

AGENT FOR INHIBITING IRON UPTAKE INTO CELLS

#7 | 2019-06-13 ✅ Patent 11,951,168 granted on 2024-04-09
US20190175736A1
Human necessities

Composition containing buffer

#8 | 2016-07-14
US20160200799A1
Chemistry; metallurgy

ANTI-INFLUENZA VIRUS NEUTRALIZING ANTIBODY

#9 | 2016-07-07 ✅ Patent 10,030,071 granted on 2018-07-24
US20160194400A1
Chemistry; metallurgy

Antibody which specifically reacts with human integrin A6B4

#10 | 2016-06-02 ✅ Patent 9,644,028 granted on 2017-05-09
US20160152703A1
Chemistry; metallurgy

Anti-CDH3 humanized antibody, drug conjugate thereof, and use thereof

#11 | 2016-03-03 ✅ Patent 9,764,041 granted on 2017-09-19
US20160058883A1
Human necessities

Drug conjugate comprising anti-CDH3 (P-cadherin) antibody

#12 | 2015-10-15 ✅ Patent 9,593,165 granted on 2017-03-14
US20150291697A1
Chemistry; metallurgy

Antibody capable of specifically recognizing transferrin receptor

#13 | 2015-10-15 ✅ Patent 9,644,029 granted on 2017-05-09
US20150291694A1
Chemistry; metallurgy

Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody

#14 | 2015-05-14 ✅ Patent 9,513,292 granted on 2016-12-06
US20150132782A1
Physics

Method for diagnosing cancer by detecting GPC3

#15 | 2014-11-06
US20140328754A1
Human necessities

RADIOACTIVE METAL-LABELED ANTI-CADHERIN ANTIBODY

#16 | 2014-08-07 ✅ Patent 9,127,061 granted on 2015-09-08
US20140221620A1
Chemistry; metallurgy

Anti-human P-cadherin (CDH3) recombinant antibody

#17 | 2014-04-24 ✅ Patent 9,598,496 granted on 2017-03-21
US20140114054A1
Chemistry; metallurgy

Antibody capable of specifically recognizing transferrin receptor

#18 | 2014-01-02 ✅ Patent 9,273,140 granted on 2016-03-01
US20140004536A1
Chemistry; metallurgy

Antibody for detecting DNA damage in cells utilizing cell membrane surface antigen Ly6D

#19 | 2013-11-28 ✅ Patent 9,328,160 granted on 2016-05-03
US20130317201A1
Chemistry; metallurgy

Anti-CDH3 antibody having high internalization capacity

#20 | 2013-09-19
US20130245232A1
Chemistry; metallurgy

HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO

#21 | 2013-09-19 ✅ Patent 9,017,683 granted on 2015-04-28
US20130243771A1
Chemistry; metallurgy

Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo

#22 | 2013-03-21 ✅ Patent 8,815,211 granted on 2014-08-26
US20130071324A1
Chemistry; metallurgy

Radioactive metal-labeled anti-cadherin antibody

#23 | 2012-05-31 ✅ Patent 8,455,249 granted on 2013-06-04
US20120136140A1
Human necessities

Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo

#24 | 2012-05-24 ✅ Patent 8,398,981 granted on 2013-03-19
US20120128694A1
Physics

Therapeutic agents for alzheimer's disease and cancer

#25 | 2012-02-16 ✅ Patent 8,546,537 granted on 2013-10-01
US20120039879A1
Human necessities

Streptavidin having low immunogenicity and use thereof

#26 | 2012-01-05 ✅ Patent 9,155,805 granted on 2015-10-13
US20120003149A1
Human necessities

Monoclonal antibody, and use thereof

#27 | 2011-11-24 ✅ Patent 8,273,859 granted on 2012-09-25
US20110288278A1
Physics

Diagnostic agent and therapeutic agent for pancreatic cancer

#28 | 2011-07-07 ✅ Patent 8,394,376 granted on 2013-03-12
US20110165179A1
Physics

Therapeutic agents for alzheimer's disease and cancer

#29 | 2011-04-07 ✅ Patent 9,376,475 granted on 2016-06-28
US20110082284A1
Chemistry; metallurgy

Gene overexpressed in cancer

#30 | 2010-12-16 ✅ Patent 8,211,630 granted on 2012-07-03
US20100316568A1
Physics

Diagnostic agent and therapeutic agent for pancreatic cancer

#31 | 2010-03-11 ✅ Patent 7,955,807 granted on 2011-06-07
US20100062449A1
Chemistry; metallurgy

Method of measuring PTX3 with high sensitivity

#32 | 2010-02-18
US20100041167A1
Physics

DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE

#33 | 2009-09-10 ✅ Patent 9,434,775 granted on 2016-09-06
US20090226918A1
Chemistry; metallurgy

Gene overexpressed in cancer

#34 | 2009-07-30 ✅ Patent 7,812,128 granted on 2010-10-12
US20090192108A1
Chemistry; metallurgy

Gene overexpressed in cancer

#35 | 2009-04-09 ✅ Patent 7,875,705 granted on 2011-01-25
US20090092544A1
Chemistry; metallurgy

Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody

#36 | 2008-06-12 ✅ Patent 7,691,586 granted on 2010-04-06
US20080138827A1
Physics

Method for predicting and judging the recurrence of liver cancer after treating liver cancer

#37 | 2007-09-13 ✅ Patent 8,940,488 granted on 2015-01-27
US20070212359A1
Physics

Cancer diagnosis and treatment of cancer using anti-robo 1 antibody

#38 | 2007-02-15
US20070037204A1
Chemistry; metallurgy

Gene overexpressed in cancer

#39 | 2006-01-19
US20060014223A1
Physics

Method for diagnosing cancer by detecting gpc3

Also check out Perseus Proteomics Inc.'s (Tokyo, Japan) applicant profile with 11 patent applications submitted.

AssigneeID:

14755 ⎘